Logo image of CGNX

COGNEX CORP (CGNX) Stock Fundamental Analysis

NASDAQ:CGNX - Nasdaq - US1924221039 - Common Stock - Currency: USD

34.34  -0.4 (-1.15%)

After market: 34.34 0 (0%)

Fundamental Rating

6

Overall CGNX gets a fundamental rating of 6 out of 10. We evaluated CGNX against 125 industry peers in the Electronic Equipment, Instruments & Components industry. CGNX gets an excellent profitability rating and is at the same time showing great financial health properties. While showing a medium growth rate, CGNX is valued expensive at the moment. With these ratings, CGNX could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CGNX had positive earnings in the past year.
In the past year CGNX had a positive cash flow from operations.
In the past 5 years CGNX has always been profitable.
CGNX had a positive operating cash flow in each of the past 5 years.
CGNX Yearly Net Income VS EBIT VS OCF VS FCFCGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of CGNX (6.09%) is better than 80.80% of its industry peers.
Looking at the Return On Equity, with a value of 8.15%, CGNX is in the better half of the industry, outperforming 70.40% of the companies in the same industry.
CGNX's Return On Invested Capital of 5.97% is fine compared to the rest of the industry. CGNX outperforms 68.80% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CGNX is in line with the industry average of 9.16%.
Industry RankSector Rank
ROA 6.09%
ROE 8.15%
ROIC 5.97%
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
CGNX Yearly ROA, ROE, ROICCGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CGNX has a Profit Margin of 12.80%. This is amongst the best in the industry. CGNX outperforms 89.60% of its industry peers.
CGNX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 13.80%, CGNX belongs to the top of the industry, outperforming 88.80% of the companies in the same industry.
In the last couple of years the Operating Margin of CGNX has declined.
CGNX's Gross Margin of 68.30% is amongst the best of the industry. CGNX outperforms 97.60% of its industry peers.
CGNX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.8%
PM (TTM) 12.8%
GM 68.3%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
CGNX Yearly Profit, Operating, Gross MarginsCGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CGNX is destroying value.
CGNX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CGNX has been reduced compared to 5 years ago.
There is no outstanding debt for CGNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CGNX Yearly Shares OutstandingCGNX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CGNX Yearly Total Debt VS Total AssetsCGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 8.34 indicates that CGNX is not in any danger for bankruptcy at the moment.
The Altman-Z score of CGNX (8.34) is better than 86.40% of its industry peers.
There is no outstanding debt for CGNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.34
ROIC/WACC0.63
WACC9.45%
CGNX Yearly LT Debt VS Equity VS FCFCGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CGNX has a Current Ratio of 3.14. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CGNX (3.14) is better than 64.00% of its industry peers.
CGNX has a Quick Ratio of 2.31. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
CGNX has a better Quick ratio (2.31) than 64.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.14
Quick Ratio 2.31
CGNX Yearly Current Assets VS Current LiabilitesCGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.86% over the past year.
CGNX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.03% yearly.
Looking at the last year, CGNX shows a quite strong growth in Revenue. The Revenue has grown by 8.57% in the last year.
The Revenue has been growing slightly by 4.74% on average over the past years.
EPS 1Y (TTM)12.86%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%45.45%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%2.49%

3.2 Future

CGNX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.50% yearly.
The Revenue is expected to grow by 2.22% on average over the next years.
EPS Next Y17.7%
EPS Next 2Y23.05%
EPS Next 3Y23.06%
EPS Next 5Y25.5%
Revenue Next Year5.58%
Revenue Next 2Y7.89%
Revenue Next 3Y8.81%
Revenue Next 5Y2.22%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CGNX Yearly Revenue VS EstimatesCGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CGNX Yearly EPS VS EstimatesCGNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 43.47, the valuation of CGNX can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as CGNX.
When comparing the Price/Earnings ratio of CGNX to the average of the S&P500 Index (27.41), we can say CGNX is valued expensively.
A Price/Forward Earnings ratio of 30.65 indicates a quite expensive valuation of CGNX.
CGNX's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of CGNX to the average of the S&P500 Index (35.19), we can say CGNX is valued inline with the index average.
Industry RankSector Rank
PE 43.47
Fwd PE 30.65
CGNX Price Earnings VS Forward Price EarningsCGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CGNX's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, CGNX is valued a bit cheaper than the industry average as 65.60% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 35.48
EV/EBITDA 34.4
CGNX Per share dataCGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CGNX has a very decent profitability rating, which may justify a higher PE ratio.
CGNX's earnings are expected to grow with 23.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.46
PEG (5Y)N/A
EPS Next 2Y23.05%
EPS Next 3Y23.06%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.92%, CGNX is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.82, CGNX pays a better dividend. On top of this CGNX pays more dividend than 86.40% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, CGNX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.92%

5.2 History

The dividend of CGNX is nicely growing with an annual growth rate of 8.39%!
CGNX has been paying a dividend for at least 10 years, so it has a reliable track record.
CGNX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)8.39%
Div Incr Years3
Div Non Decr Years3
CGNX Yearly Dividends per shareCGNX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

45.00% of the earnings are spent on dividend by CGNX. This is a bit on the high side, but may be sustainable.
The dividend of CGNX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP45%
EPS Next 2Y23.05%
EPS Next 3Y23.06%
CGNX Yearly Income VS Free CF VS DividendCGNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CGNX Dividend Payout.CGNX Dividend Payout, showing the Payout Ratio.CGNX Dividend Payout.PayoutRetained Earnings

COGNEX CORP

NASDAQ:CGNX (7/11/2025, 8:00:00 PM)

After market: 34.34 0 (0%)

34.34

-0.4 (-1.15%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners102.03%
Inst Owner Change-0.07%
Ins Owners0.27%
Ins Owner Change1.27%
Market Cap5.76B
Analysts75.38
Price Target37.69 (9.76%)
Short Float %3.35%
Short Ratio2.7
Dividend
Industry RankSector Rank
Dividend Yield 0.92%
Yearly Dividend0.31
Dividend Growth(5Y)8.39%
DP45%
Div Incr Years3
Div Non Decr Years3
Ex-Date05-15 2025-05-15 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.47%
Min EPS beat(2)18.89%
Max EPS beat(2)26.05%
EPS beat(4)4
Avg EPS beat(4)14.69%
Min EPS beat(4)3.88%
Max EPS beat(4)26.05%
EPS beat(8)8
Avg EPS beat(8)17.05%
EPS beat(12)10
Avg EPS beat(12)17.53%
EPS beat(16)12
Avg EPS beat(16)14.67%
Revenue beat(2)1
Avg Revenue beat(2)0.75%
Min Revenue beat(2)-0.55%
Max Revenue beat(2)2.05%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-2.41%
Max Revenue beat(4)2.05%
Revenue beat(8)4
Avg Revenue beat(8)0.47%
Revenue beat(12)6
Avg Revenue beat(12)0.4%
Revenue beat(16)9
Avg Revenue beat(16)0.67%
PT rev (1m)1.06%
PT rev (3m)-12.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.17%
EPS NY rev (1m)0.29%
EPS NY rev (3m)-1.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.71%
Valuation
Industry RankSector Rank
PE 43.47
Fwd PE 30.65
P/S 6.27
P/FCF 35.48
P/OCF 32.76
P/B 3.99
P/tB 5.98
EV/EBITDA 34.4
EPS(TTM)0.79
EY2.3%
EPS(NY)1.12
Fwd EY3.26%
FCF(TTM)0.97
FCFY2.82%
OCF(TTM)1.05
OCFY3.05%
SpS5.48
BVpS8.61
TBVpS5.75
PEG (NY)2.46
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.09%
ROE 8.15%
ROCE 7.26%
ROIC 5.97%
ROICexc 6.74%
ROICexgc 9.78%
OM 13.8%
PM (TTM) 12.8%
GM 68.3%
FCFM 17.66%
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
ROICexc(3y)9.56%
ROICexc(5y)11.82%
ROICexgc(3y)12.73%
ROICexgc(5y)15.09%
ROCE(3y)9.35%
ROCE(5y)11.55%
ROICexcg growth 3Y-25.69%
ROICexcg growth 5Y-4.75%
ROICexc growth 3Y-29.85%
ROICexc growth 5Y-7.09%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
F-Score7
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 41.45%
Cap/Sales 1.47%
Interest Coverage 250
Cash Conversion 110.32%
Profit Quality 137.97%
Current Ratio 3.14
Quick Ratio 2.31
Altman-Z 8.34
F-Score7
WACC9.45%
ROIC/WACC0.63
Cap/Depr(3y)84%
Cap/Depr(5y)75.71%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.9%
Profit Quality(3y)103.13%
Profit Quality(5y)109.22%
High Growth Momentum
Growth
EPS 1Y (TTM)12.86%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%45.45%
EPS Next Y17.7%
EPS Next 2Y23.05%
EPS Next 3Y23.06%
EPS Next 5Y25.5%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%2.49%
Revenue Next Year5.58%
Revenue Next 2Y7.89%
Revenue Next 3Y8.81%
Revenue Next 5Y2.22%
EBIT growth 1Y10.7%
EBIT growth 3Y-28.52%
EBIT growth 5Y-4.2%
EBIT Next Year47.56%
EBIT Next 3Y29.51%
EBIT Next 5Y20.51%
FCF growth 1Y-19.14%
FCF growth 3Y-23.43%
FCF growth 5Y-10.36%
OCF growth 1Y-20.57%
OCF growth 3Y-22%
OCF growth 5Y-10.06%